Durability of XBB.1.5 Vaccines against Omicron Subvariants

A data survey of 1.8 million people in Nebraska showed that XBB.1.5 vaccine effectiveness was 52% against infection and 67% against hospitalization, despite a decline in circulating XBB.1.5 during data collection.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2024-06, Vol.390 (22), p.2124-2127
Hauptverfasser:	Lin, Dan-Yu, Du, Yi, Xu, Yangjianchen, Paritala, Sai, Donahue, Matthew, Maloney, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Antibodies, Viral - blood Coronavirus COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - immunology Data collection Effectiveness Hospitalization Humans Immunization Immunogenicity, Vaccine Infections Infectious Disease SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Statistical analysis Vaccine efficacy Vaccines Viral Infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A data survey of 1.8 million people in Nebraska showed that XBB.1.5 vaccine effectiveness was 52% against infection and 67% against hospitalization, despite a decline in circulating XBB.1.5 during data collection.
ISSN:	0028-4793 1533-4406 1533-4406
DOI:	10.1056/NEJMc2402779